Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UK post
#SSACAB
|
#Scienceforafricafoundation
|
#Wellocmetrust
|
#Vaccines
|
#GlobalHealth
|
#PCV13
|
#PneumococcalDisease
|
#MedicalResearch
|
#PublicHealth
|
#SSACAB
|
#ResearchExcellence
|
#ScientificCollaboration
|
#AfricaInScience
A recent study titled “ Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UK ” presents important evidence on the efficacy of the PCV13 pneumococcal vaccine using data from controlled human infection models conducted across Malawi and the United Kingdom.
The study provides valuable insights into vaccine performance across different settings, strengthening the global evidence base for pneumococcal disease prevention and informing future vaccine policy and development. It also highlights the importance of international collaboration in addressing persistent global health challenges.
A special congratulations to Evaristar Kudowa, a SSACAB Fellow and one of the authors of this important publication. Under the mentorship of Professor Samuel Manda, a leading expert in biostatistics and SSACAB Principal Investigator, Evaristar's contribution highlights the impact of strong mentorship and collaborative research.
This achievement reflects the growing contribution of SSACAB Fellows to high-impact global health research and scientific advancement, while demonstrating the Consortium's commitment to developing the next generation of biostatistical researchers in Africa. 👏🌍📚
Congratulations to all the authors and collaborators on this impactful work.
🔗 Read the publication: https://www.nature.com/articles/s41541-026-01381-4